期刊文献+

SPA预处理对小鼠金葡菌致死性攻击的保护作用 被引量:3

Pretreatment with SPA protects mice from lethal challenged with live Staphylococcus aureus
下载PDF
导出
摘要 目的:探讨金葡菌A蛋白(SPA)预处理小鼠对金葡菌致死性攻击的保护作用。方法:于0、24小时对BALB/c小鼠行腹腔注射SPA 20μg/只/次,对照组以生理盐水替代SPA。第二次处理24小时后,腹腔注射致死量(3×1010CFU/kg)金葡菌(ATCC25923),观察小鼠生存率;非致死量金葡菌(2×108CFU/只)腹腔感染6小时后,ELISA、Q-PCR检测小鼠血清及脾脏中TNF-α、IL-6、IFN-γ含量及表达量。结果:与对照组小鼠2天内全部死亡比较,致死量细菌攻击后,SPA预处理组小鼠2周生存率为30%,显著高于对照组(P<0.05);非致死量细菌感染后,预处理组小鼠血清及脾脏中TNF-α、IL-6、IFN-γ含量及表达量显著低于对照组(P<0.05),IL-10表达量降低。结论:SPA预处理增强BALB/c小鼠抵御S.aureus致死攻击。 Objective: To study the protective effect of SPA pretreatment on mice challenged with lethal-dose Staphylococcus aureus. Methods : BALB/c mice were given intraperitoneal injections ( i. p) of 20 μg SPA or normal saline at 0 h and 24 h on consecutive 2 days. All of mice were then challenged by an i. p injection of live Sthaphylococcus aureus (ATCC25923) with lethal-dose (3×10^10CFU/kg) at 1 day after the second pretreatment. The mice mortality was observed, and the serum level of IFN-γ, TNF-α and IL- 6 in mice infected with non-lethal live Staphylococcus aureus (2×10^8 CFU for each, i. p) were detected by ELISA. Meanwhile, the gene relative expression of these cytokines in splenocyte was detected by Q-PCR. Results: Compared with normal saline treated, the pretreated with SPA prolonged significantly the survival of mice challenged with lethal live S. aureus ( P 〈 0.05 ). The level and gene relative expression of TNF-α, IL-6, IFN-γ and IL-10 of serum and splenocyte in mice that were administrated with SPA were reduced ( P 〈 0. 05 ). Conclusion : Pretreatment with SPA protects the mice from challenge with lethal and non-lethal live S. aureues.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2013年第4期403-406,共4页 Chinese Journal of Immunology
基金 国家自然科学基金(项目号31270980) 广东省自然科学基金(S2012010009562)资助
关键词 金葡菌 金葡菌A蛋白 感染 细胞因子 Staphylococcus aureus (S. aureus) Protein A of S. aureus (SPA) Infection Cytokines
  • 相关文献

参考文献19

  • 1Styers D, Sheehan D J, Hogan Pet al. Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States [ J]. Ann Clin Microbiol Antimicrob, 2006;5:2.
  • 2朱德妹,胡付品,汪复,阮斐怡,倪语星,孙景勇,俞云松,杨青,王传清,薛建昌,徐英春,孙宏莉,张泓,李万华,孙自镛,简翠,胡云健,艾效曼,苏丹虹,卓超,魏莲花,吴玲,贾蓓,黄文祥,张朝霞,季萍.2007年中国CHINET葡萄球菌属耐药性监测[J].中国感染与化疗杂志,2009,9(3):168-174. 被引量:49
  • 3Forsgren A, Sjoquist J, "Protein A" from S. aureus. I. Pseudoim- mune reaction with human gamma-globulin [ J ], J Immunol, 1966 ; 97 : 822-827.
  • 4Classen A, Kalali B N, Schnopp C et al. TNF receptor I on human keratinocytes is a binding partner for staphylococcal protein A resulting in the activation of NF kappa B, AP-1, and downstream gene transcription [J]. Exp Dermatol, 2010 ; 20 : 48-52.
  • 5Goodyear C S. and Silverman G J. Staphylococcal toxin induced preferential and prolonged in vivo deletion of innate-like B lymphocytes [J]. PNAS, 2004; 101: 11392-11397.
  • 6Silverman G J, Cary S P, Dwyer D C et al. A B cell Superantigen-in- duced persistent "Hole" in the B-1 repertoire [J]. J Exp Med, 2000 ; 192 : 87-98.
  • 7Claro T, Widaa A, O' Seaghdha M et al. Staphylococcus aureus protein a binds to osteoblasts and triggers signals that weaken bone in osteomyelitis [J]. PLoS ONE, 2011; 6 : e18748.
  • 8Widaa A, Claro T, Foster T J et al. Staphylococcus aureus protein A plays a critical role in mediating bone destruction and bone loss in osteomyelitis [J]. PLoS ONE, 2012; 7 : e40586.
  • 9Palmqvist N, Foster T, Tarkowski A et al. Protein A is a virulence factor in Staphylococcus aureus arthritis and septic death [J]. Microbial Pathogenesis, 2002; 33: 239-249.
  • 10Merino N, Toledo-Arana A, Vergara-Irigaray Met al. Protein A-mediated muhicellular behavior in Staphylococcus aureus [J]. J Bacterial, 2009 ; 191:832-843.

二级参考文献11

  • 1Clinical and Laboratory Standads Institute. Performance Standards for Antimicrobial Susceptibility Testing [S]. Fifteenth Informational Supplement, 2007, M100-S17.
  • 2Sakoulas G, Moellering RC Jr. Increasing antibiotic resistamong methicillin-resistant Staphylococcus aureus strains[J]. Clin Infect Dis,2008,46(S5) :S360-S367.
  • 3Ball JM,Walters LJ,Turnidge D, et al. hVISA are commom among vacomycin-susceptible methicillin-Staphylococcus aureus (MRSA) : report from SENTRY Asia-Pacific regio [abstract C2-1160] [C]//Program and abstracts of 46th annual meeting of the Interscience Conferenee on AntimicrobialAgents and Chemotherapy (San Francisco). Washington , DC:American Society for Microbiology,2006.
  • 4Clinical and Laboratory Standads Institute. Performance Standards for Antimicrobial Susceptibility Testing [S]. Fifteenth Informational Supplement, 2006, M100-S16.
  • 5Soriano A, Marco F, Martinnez JA,et al. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia [J]. Clin Infect Dis, 2008, 46(2):193-200.
  • 6Clinical and Laboratory Standads Institute. Performance Standards for Antimierobial Susceptibility Testing [S]. Fifteenth Informational Supplement, 2009, M100-S19.
  • 7Wootton M,Howe RA,Hillman R,et al. A modified population analysis profile (PAP) method to detect hetero resistance to vancomycin in Staphylococcus aureus in a UK hospital[J]. J Anitimicrob Chemother,2001,47(4) :399-403.
  • 8Appelbaum PC. Microbiology of antibiotic resistance in Stapylococcus aureus[J]. Clin Infect Dis, 2007, 45 (Suppl 3) : S165-S170.
  • 9Walsh TR, Bolmstrom A, Qwarstrom A, et al. Evaluation of current methods for detection of staphylococci with reduced susceptibility to glyeopeptides[J]. J Clin Microbiol, 2001, 39(7) :2439-2444.
  • 10朱德妹.2005年中国CHINET葡萄球菌属耐药性分析[J].中国感染与化疗杂志,2007,7(4):269-273. 被引量:72

共引文献48

同被引文献48

  • 1李刚,祁晓平,许哲,陈彻,杨小冬,吴晓宇,孙正,黎介寿.钙通道阻滞剂对炎症因子平衡的影响及肝保护作用[J].肠外与肠内营养,2005,12(6):325-328. 被引量:3
  • 2World Health Organization. 2013 Global tuberculosis report[R]. Geneva: WHO, 2013.
  • 3Gupta S, Salam N, Srivastava V, et al. Voltage gated calcium channels negatively regulate protective immunity to Mycobacteri- umtuberculosis[J]. PLoSOne, 2009, 4(4): 5305.
  • 4Danelishvili L, MeGarvey J, Li YJ, et al. Mycobacterium tuber- culosis infection causes different levels of apoptosis and necrosis in human macrophages and alveolar epithelial cells[J]. Cell Microbi- ol, 2003, 5(9): 649-60.
  • 5Bradfute S, Castillo EF, Arko Mensah J, et al. Autophagy as an immune effector against tuberculosis[J]. Curr Opin Microbiol, 2013, 16(1): 1105-11.
  • 6Tran MT, Lauscb RN, Oakes JE. Substance P differentially stimulates IL-8 synthesis in human corneal epithelial[J]. Invest Ophth Vis Sci, 2000, 41(12): 3871-7.
  • 7Keane J, Remold HG, Kornfeld H. Virulent myeobaeterium tu- berculosis strains evade apoptosis of infected alveolar macrophages [J]. J Immunol, 2000, 164(4): 2016 -20.
  • 8Duan L, Gan H, Golan DE, et al. Critical Role of mitochondrial damage in determining outcome of macrophage Infection with My- cobacterium tuberculosis[J]. J Immunol, 2002, 169 (9) : 5181- 7.
  • 9Vergne I, Chua J, Deretic V. Tuberculosis toxin blocking pha- gosome maturation inhibits a novel Ca2+/calmodulin PI3K hVPS34 cascade[J]. J Exp Med, 2003, 198(4) : 653-9.
  • 10Genestier AL, Michallet MC, Prevost G, et al. Staphylococcus aureus isolates carrying panton-valetine leukocidin directly targets mitochondria and induces Bax-independent apoptosis of human neutrophils[J]. Clinlnvest, 2005, 115 (11): 3117-27.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部